Concomitant Diabetes and Heart Disease? Have no Fear! A Comparative Review of GLP-1 Agonists vs. SGLT2 inhibitors in Cardiovascular Benefits

Slidell, LA US
April 29, 2020

All new medications for type 2 diabetes since 2008 were mandated by the FDA to undergo long-term cardiovascular outcome trials due to safety. During these trials, cardiovascular benefit was found with SGLT inhibitors and GLP-1 agonists which led to new indications for these medications. Reviewing these new medications with seasoned pharmacists and technicians will provide a baseline of these medications. The indications are a great importance to Slidell Memorial Hospital’s patients due to the majority of them being cardiac patients. Due to this, our pharmacists and technicians should understand how these medications work and when they are recommended.

Target Audience

  • Pharmacists
  • Pharmacy technicians

Learning Objectives

Pharmacist learning objectives

  1. Discuss each group’s roles in diabetic treatment
  2. Assess cardiovascular risk and benefit in diabetic patients for each group
  3. Apply information to a specific patient case

Pharmacy technician learning objectives

  1. List the GLP-1 agonists and SGLT2 inhibitors
  2. Examine the mechanism of action, warnings, adverse effects, and dosing adjustments of GLP-1 agonists and SGLT2 inhibitors
Course summary
Available credit: 
  • 1.00 ACPE Pharmacy
  • 1.00 ACPE Technician
  • 1.00 General CEU – Attendance
Course opens: 
04/09/2020
Course expires: 
06/14/2020
Event starts: 
04/29/2020 - 11:00am
Event ends: 
04/29/2020 - 12:00pm
Cost:
$0.00
Slidell Memorial Hospital
1001 Gause Blvd.
Slidell, LA 70458
United States
Relevant financial relationships: Planning committee members and presenters have nothing to disclose
 
Planning committee members
Chelsey E. Bourgeois, PharmD
PGY1 Pharmacy Resident
Slidell Memorial Hospital
 
India Scales, PharmD
Clinical Pharmacist/PGY1 Preceptor
Slidell Memorial Hospital
 
Kisha Gant, PharmD, BCPS, BCGP, BCCP
Director of Pharmacy/PGY1 Residency Director
Slidell Memorial Hospital
 
Course reviewer
James Lichauer, PharmD, BCPS, FASHP
PI Program Director, Pharmacy
Vizient
 
Presenter
Chelsey E. Bourgeois, PharmD
PGY1 Pharmacy Resident
Slidell Memorial Hospital
Joint Accreditation Statement:
 
In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and Slidell Memorial Hospital.  Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
____________________________________________
 
Designation Statements:
 
PHARMACY
Vizient, Inc. designates this activity for a maximum of 1.00 ACPE credit hours.
Universal Activity Number: JA0006103-9999-20-082-L01-P
Universal Activity Number: JA0006103-9999-20-082-L01-T
 
CEU
Vizient, Inc. will award CEUs to each participant who successfully completes this program. The CEU is a nationally recognized unit of measure for continuing education and training programs that meet certain criteria (1 contact hour = 0.1 CEU).

Available Credit

  • 1.00 ACPE Pharmacy
  • 1.00 ACPE Technician
  • 1.00 General CEU – Attendance

Price

Cost:
$0.00
Please login or register to take this course.